Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

Biotechnology and pharmaceutical researchers are increasingly relying on High Throughput Screening (HTS) methods to discover new leads that may ultimately be transformed into novel drugs.


With this in mind, GEN recently held a Current Trends in HTS roundtable at our offices in New Rochelle, NY. We invited four industry scientists to provide their perspectives on the recent state of HTS in bioresearch and to give us their thoughts on where the technology might be headed.


Members of the roundtable included: Dejan Bojanic, Ph.D., Head of Lead Finding Platform, Novartis Institutes for BioMedical Research; Richard M. Eglen, Ph.D., President, Bio-discovery, PerkinElmer; Stephan Heyse, Ph.D., Head of Lead Discovery Informatics, Genedata; and Berta Strulovici, Ph.D., Vice President Basic Research, Automated Biotechnology Head, Merck Research Laboratories. The moderator was John Sterling, Editor-in-Chief of GEN.


We hope you find the podcast stimulating and that it helps you think of new ways to carry out your own HTS research.

Members of the roundtable included: Dejan Bojanic, Ph.D., Head of Lead Finding Platform, Novartis Institutes for BioMedical Research; Richard M. Eglen, Ph.D., President, Bio-discovery, PerkinElmer; Stephan Heyse, Ph.D., Head of Lead Discovery Informatics, Genedata; and Berta Strulovici, Ph.D., Vice President Basic Research, Automated Biotechnology Head, Merck Research Laboratories. The moderator was John Sterling, Editor-in-Chief of GEN.


Related content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

GEN Articles

MORE RELATED GEN ARTICLES

New Products

MORE RELATED NEW PRODUCTS

Best of the Web

MORE RELATED BEST OF THE WEB

Subscription center

BACK TO TOP

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll
« More »     « View Results »     « Poll Archive »